A Randomized Prospective Trial of Conversion to Everolimus Therapy From Calcineurin Inhibitor Based Maintenance Immunosuppression in Association With Mycophenolic Acid in Liver Transplantation: Examination of Impact on Long Term Renal Function.
Phase of Trial: Phase IV
Latest Information Update: 04 Oct 2016
At a glance
- Drugs Everolimus (Primary) ; Ciclosporin; Mycophenolic acid; Tacrolimus
- Indications Liver transplant rejection; Renal failure
- Focus Therapeutic Use
- 26 Sep 2016 Planned End Date changed from 1 Apr 2017 to 1 Dec 2019.
- 26 Sep 2016 Planned primary completion date changed from 1 Apr 2017 to 1 Oct 2019.
- 10 Sep 2013 New trial record